Delivery Order SPE2DB22D1106-SPE2DB25FEZH2
- Not listed
- The Defense Logistics Agency awarded a $3,914.81 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, representing part of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,262.72 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- The Defense Logistics Agency awarded a $13,509.57 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $6,151.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit dose packages) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used to treat chronic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,302.30 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). Issued on May 6, 2025, with an ultimate completion date of May 7, 2025, this firm fixed-price delivery order represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $4,617.18 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Vemlidy is a prescription antiviral medication used in hepatitis B treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $5,673.10 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, with a contract ceiling value of $3,329.67. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for ultimate completion on June 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $16,140.89. This delivery order represents a firm fixed price contract with no set-aside designation, utilizing open and competitive procurement practices. The contract is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZH2Delivery Order
The Defense Logistics Agency awarded a $40,852.26 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of July 24, 2025, with performance to take place at the vendor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used primarily in the treatment of chronic hepatitis B, reflecting the Defense Logistics Agency's ongoing medical supply requirements for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical supplier to federal medical procurement needs, including the Defense Health Agency and other government healthcare systems. The non-set-aside designation and delivery order structure demonstrate the company's established capability and competitive standing within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.9k | 7/23/25 |